Get startedLog in
    Picture of China Medical System Holdings logo

    867 — China Medical System Holdings News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: China Medical System Receives Approval For Clinical Trials Of Jak1 Inhibitor POVORCITINIB

    Picture of China Medical System Holdings logoChina Medical System Holdings
    28/08/2025 15:57
    Aug 28 (Reuters) - China Medical System Holdings Ltd 0867.HK:

APPROVAL FOR CLINICAL TRIALS OF JAK1 INHIBITOR POVORCITINIB

NMPA APPROVES CLINICAL TRIALS FOR POVORCITINIB

Further company coverage: 0867.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on China Medical System Holdings

    See all news